These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 15781654

  • 41. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [Abstract] [Full Text] [Related]

  • 42. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
    Besch R, Berking C, Kammerbauer C, Degitz K.
    Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Aspirin upregulates expression of urokinase type plasminogen activator receptor (uPAR) gene in human colon cancer cells through AP1.
    Jamaluddin MS.
    Biochem Biophys Res Commun; 2006 Sep 22; 348(2):618-27. PubMed ID: 16893520
    [Abstract] [Full Text] [Related]

  • 45. Profiling the evolution of human metastatic bladder cancer.
    Nicholson BE, Frierson HF, Conaway MR, Seraj JM, Harding MA, Hampton GM, Theodorescu D.
    Cancer Res; 2004 Nov 01; 64(21):7813-21. PubMed ID: 15520187
    [Abstract] [Full Text] [Related]

  • 46. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
    Wang L, Madigan MC, Chen H, Liu F, Patterson KI, Beretov J, O'Brien PM, Li Y.
    Gynecol Oncol; 2009 Aug 01; 114(2):265-72. PubMed ID: 19450871
    [Abstract] [Full Text] [Related]

  • 47. Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse.
    Ossowski L, Russo-Payne H, Wilson EL.
    Cancer Res; 1991 Jan 01; 51(1):274-81. PubMed ID: 1988089
    [Abstract] [Full Text] [Related]

  • 48. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
    Mitra SK, Lim ST, Chi A, Schlaepfer DD.
    Oncogene; 2006 Jul 27; 25(32):4429-40. PubMed ID: 16547501
    [Abstract] [Full Text] [Related]

  • 49. Effect of radiation-induced injury of tumor bed stroma on metastatic spread of murine sarcomas and carcinomas.
    Milas L, Hirata H, Hunter N, Peters LJ.
    Cancer Res; 1988 Apr 15; 48(8):2116-20. PubMed ID: 3349483
    [Abstract] [Full Text] [Related]

  • 50. Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.
    Harrell JC, Dye WW, Allred DC, Jedlicka P, Spoelstra NS, Sartorius CA, Horwitz KB.
    Cancer Res; 2006 Sep 15; 66(18):9308-15. PubMed ID: 16982776
    [Abstract] [Full Text] [Related]

  • 51. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
    Man S, Munoz R, Kerbel RS.
    Cancer Metastasis Rev; 2007 Dec 15; 26(3-4):737-47. PubMed ID: 17846863
    [Abstract] [Full Text] [Related]

  • 52. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells.
    Yano A, Fujii Y, Iwai A, Kageyama Y, Kihara K.
    Clin Cancer Res; 2006 May 15; 12(10):3003-9. PubMed ID: 16707595
    [Abstract] [Full Text] [Related]

  • 53. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G, Daniele B, Di Blasi A, Napolitano M, Ieranò C, Calemma R, Leonardi E, Albino V, De Angelis V, Falanga M, Boccia V, Capuozzo M, Parisi V, Botti G, Castello G, Vincenzo Iaffaioli R, Scala S.
    Clin Cancer Res; 2006 May 01; 12(9):2795-803. PubMed ID: 16675573
    [Abstract] [Full Text] [Related]

  • 54. Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.
    Cruz-Munoz W, Man S, Xu P, Kerbel RS.
    Cancer Res; 2008 Jun 15; 68(12):4500-5. PubMed ID: 18559492
    [Abstract] [Full Text] [Related]

  • 55. Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1.
    van Herpen CM, Bussink J, van der Kogel AJ, Peeters WJ, van der Voort R, van Schijndel A, de Wilde PC, Adema GJ, de Mulder PH.
    Anticancer Res; 2005 Jun 15; 25(2A):1015-21. PubMed ID: 15868941
    [Abstract] [Full Text] [Related]

  • 56. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
    Colombo ES, Menicucci G, McGuire PG, Das A.
    Invest Ophthalmol Vis Sci; 2007 Apr 15; 48(4):1793-800. PubMed ID: 17389513
    [Abstract] [Full Text] [Related]

  • 57. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B, Bianchi F, Dey J, Moreno E, Djaffer S, Hynes NE, Monard D.
    Cancer Res; 2009 Jul 15; 69(14):5690-8. PubMed ID: 19584287
    [Abstract] [Full Text] [Related]

  • 58. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.
    Shariat SF, Roehrborn CG, McConnell JD, Park S, Alam N, Wheeler TM, Slawin KM.
    J Clin Oncol; 2007 Feb 01; 25(4):349-55. PubMed ID: 17264329
    [Abstract] [Full Text] [Related]

  • 59. Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.
    Dubois L, Magagnin MG, Cleven AH, Weppler SA, Grenacher B, Landuyt W, Lieuwes N, Lambin P, Gorr TA, Koritzinsky M, Wouters BG.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1219-27. PubMed ID: 19251093
    [Abstract] [Full Text] [Related]

  • 60. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
    Ikoma N, Yamazaki H, Abe Y, Oida Y, Ohnishi Y, Suemizu H, Matsumoto H, Matsuyama T, Ohta Y, Ozawa A, Ueyama Y, Nakamura M.
    Oncol Rep; 2005 Sep 15; 14(3):633-7. PubMed ID: 16077966
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.